Maine woman awarded $10 million after cancer screenings misread

Before you go, we thought you'd like these...
Before you go close icon
Maine Woman Awarded $10 Million After Cancer Screenings Misread

PORTLAND, Maine —A Maine woman who developed cervical cancer despite undergoing regular examinations has received a $10 million award in what could be the largest medical malpractice case in state history.

Ruth Hricko had regular pap-smear screenings, pelvic exams and tests, her attorney Owen Pickus said. But a jury found that a lab technician from Central Maine Medical Center misread the screenings and Hricko had abnormal cells as far back as 2009.

If the technician had found the abnormal cells in 2009, an outpatient procedure would have given Hricko a 100 percent chance of recovery, Pickus said.

In 2010, Hricko could've had a hysterectomy, which would have given her a 95 percent chance of recovery, Pickus said.

In 2011, another specialist found the cancer, which was clearly visible at that point. With treatment, she had less than a 50 percent chance of surviving the stage 3 cancer, Pickus said.

Hricko's cancer is now in remission, but that's little consolation, Pickus said.

"No one can give her back her colon. No one can give her back the injuries to her private parts. No one can give her back her small bowel if it comes out. No one can give her back her brain function injured by chemotherapy. None of those things can be fixed," he said.

"It became so painful that I couldn't even sit down," Hricko said in 2013. "Actually, I was probably sitting on the tumor and I didn't realize it."

Hricko was unavailable Wednesday because she and Pickus were preparing in case Central Maine Medical Center appeals.

Hospital officials did not respond to requests for a comment.

More on AOL:
430 migrants saved after four months at sea
Wife claims innocent bikers were arrested
34M vehicles affected in largest recall in US history
Read Full Story

Sign up for Breaking News by AOL to get the latest breaking news alerts and updates delivered straight to your inbox.

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

People are Reading